Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
ORIAU Stock Summary
In the News
ORIAU Financial details
Company Rating
Buy
Market Cap
217.4M
Income
4904.48B
Revenue
0
Book val./share
9.75
Cash/share
0.01
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
31 Dec 2022
P/E
0
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
-
P/FCF
-0.08
Quick Ratio
3.93
Current Ratio
6.5
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
196.18K
EPS next Y
-
EPS next Q
-
EPS this Y
-2904.88%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
499.02%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
7.98%
Inst Trans
0.99%
ROA
9%
ROE
10%
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
9.0-10.635
52W High
-
52W Low
-
RSI
-
Rel Volume
0.02
Avg Volume
201
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
-
-
-
Volatility
0%, 0%
Prev Close
-
Price
-
Change
-
ORIAU Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2021-12-31 | 2022-12-31 |
---|---|---|---|
2.02K | 2.02K | ||
Revenue per share | 0 | 0 | |
Net income per share | -0.03 | 0.92 | |
Operating cash flow per share | 0 | -0.02 | |
Free cash flow per share | 0 | -0.02 | |
Cash per share | 0.03 | 0.01 | |
Book value per share | 7.45 | 9.75 | |
Tangible book value per share | 7.45 | 9.75 | |
Share holders equity per share | 7.45 | 9.75 | |
Interest debt per share | 0 | -0.97 | |
Market cap | 241.79M | 201M | |
Enterprise value | 241.08M | 200.73M | |
P/E ratio | -294.58 | 10.92 | |
Price to sales ratio | 0 | 0 | |
POCF ratio | 0 | -533.5 | |
PFCF ratio | 0 | -533.5 | |
P/B Ratio | 1.3 | 1.03 | |
PTB ratio | 1.3 | 1.03 | |
EV to sales | 0 | 0 | |
Enterprise value over EBITDA | -332.75 | -19.02 | |
EV to operating cash flow | 0 | -532.8 | |
EV to free cash flow | 0 | -532.8 | |
Earnings yield | 0 | 0.09 | |
Free cash flow yield | 0 | 0 | |
Debt to equity | 0 | 0 | |
Debt to assets | 0 | 0 | |
Net debt to EBITDA | 0.98 | 0.03 | |
Current ratio | 16.57 | 6.5 | |
Interest coverage | -6.52 | 0.05 | |
Income quality | 0 | -0.04 | |
Dividend Yield | 0 | 0 | |
Payout ratio | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | |
Research and developement to revenue | 0 | 0 | |
Intangibles to total assets | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | |
Capex to revenue | 0 | 0 | |
Capex to depreciation | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | |
Graham number | 2.35 | 14.21 | |
ROIC | 0 | -0.01 | |
Return on tangible assets | 0 | 0.09 | |
Graham Net | -0.58 | -0.4 | |
Working capital | 1.27M | 371.73K | |
Tangible asset value | 186.24M | 195M | |
Net current asset value | -13.76M | -7.89M | |
Invested capital | 0 | 0 | |
Average receivables | 0 | 0 | |
Average payables | 0 | 9.67K | |
Average inventory | 0 | 0 | |
Days sales outstanding | 0 | 0 | |
Days payables outstanding | 0 | 0 | |
Days of inventory on hand | 0 | 0 | |
Receivables turnover | 0 | 0 | |
Payables turnover | 0 | 0 | |
Inventory turnover | 0 | 0 | |
ROE | 0 | 0.09 | |
Capex per share | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2022-12-31 for Q4
Metric | History | 2021-12-31 | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | -0.33 | 196.18K | 0.16 | 0.08 | 0.49 | |
Operating cash flow per share | 0 | -0.01 | -0.01 | 0 | 0 | |
Free cash flow per share | 0 | -0.01 | -0.01 | 0 | 0 | |
Cash per share | 0.14 | 0.02 | 0.02 | 0.01 | 0.01 | |
Book value per share | -2.75 | 7.63 | 7.71 | 7.75 | 9.75 | |
Tangible book value per share | -2.75 | 7.63 | 7.71 | 7.75 | 9.75 | |
Share holders equity per share | -2.75 | 7.63 | 7.71 | 7.75 | 9.75 | |
Interest debt per share | 0.14 | -0.39 | -0.17 | -0.09 | -0.15 | |
Market cap | 48.36M | 243.5M | 243.38M | 246M | 201M | |
Enterprise value | 47.65M | 242.92M | 242.96M | 245.66M | 200.73M | |
P/E ratio | -7.41 | 0 | 14.97 | 30.06 | 5.12 | |
Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
POCF ratio | 0 | -1.78K | -1.55K | -3.17K | -37.85K | |
PFCF ratio | 0 | -1.78K | -1.55K | -3.17K | -37.85K | |
P/B Ratio | -3.52 | 1.28 | 1.26 | 1.27 | 1.03 | |
PTB ratio | -3.52 | 1.28 | 1.26 | 1.27 | 1.03 | |
EV to sales | 0 | 0 | 0 | 0 | 0 | |
Enterprise value over EBITDA | -50.65 | -46.8 | -103.9 | -184.54 | -118.4 | |
EV to operating cash flow | 0 | -1.78K | -1.54K | -3.17K | -37.8K | |
EV to free cash flow | 0 | -1.78K | -1.54K | -3.17K | -37.8K | |
Earnings yield | -0.03 | 20.14K | 0.02 | 0.01 | 0.05 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0 | 0 | 0 | 0 | 0 | |
Debt to assets | 0 | 0 | 0 | 0 | 0 | |
Net debt to EBITDA | 0.76 | 0.11 | 0.18 | 0.26 | 0.16 | |
Current ratio | 16.57 | 9.95 | 20.38 | 10.92 | 6.5 | |
Interest coverage | -0.36 | 0.03 | 0.05 | 0.09 | 0.07 | |
Income quality | 0 | -0.03 | -0.08 | -0.08 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 4.49 | 5.81K | 5.31 | 3.78 | 10.38 | |
ROIC | 0.03 | -1.59K | 0 | 0 | -0.01 | |
Return on tangible assets | -1.2 | 24.39K | 0.02 | 0.01 | 0.05 | |
Graham Net | -2.88 | -0.39 | -0.32 | -0.31 | -0.4 | |
Working capital | 1.27M | 985.24K | 780.71K | 575.25K | 371.73K | |
Tangible asset value | -13.76M | 190.86M | 192.79M | 193.71M | 195M | |
Net current asset value | -13.76M | -9.17M | -7.51M | -7.49M | -7.89M | |
Invested capital | 0 | 0 | 0 | 0 | 0 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 9.11K | 17.5K | 14.33K | 9.14K | 10.35K | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0.12 | 25.7K | 0.02 | 0.01 | 0.05 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
ORIAU Frequently Asked Questions
What is Orion Biotech Opportunities Corp. stock symbol ?
Orion Biotech Opportunities Corp. is a US stock , located in New york of Ny and trading under the symbol ORIAU
What is Orion Biotech Opportunities Corp. stock quote today ?
Orion Biotech Opportunities Corp. stock price is $- today.
Is Orion Biotech Opportunities Corp. stock public?
Yes, Orion Biotech Opportunities Corp. is a publicly traded company.